Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction.

Altara, Raffaele; Giordano, Mauro; Nordén, Einar S; Cataliotti, Alessandro; Kurdi, Mazen; Bajestani, Saeed N; Booz, George W

Altara, Raffaele; Giordano, Mauro; Nordén, Einar S; Cataliotti, Alessandro; Kurdi, Mazen; Bajestani, Saeed N; Booz, George W.

Afiliação

Altara R; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.
Giordano M; KG Jebsen Center for Cardiac Research, Oslo, Norway.
Nordén ES; Department of Pathology, School of Medicine, University of Mississippi Medical Center, Jackson, MS, United States.
Cataliotti A; Department of Medical, Surgical, Neurological, Metabolic and Geriatrics Sciences, University of Campania "L. Vanvitelli", Caserta, Italy.
Kurdi M; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.
Bajestani SN; KG Jebsen Center for Cardiac Research, Oslo, Norway.
Booz GW; Bjørknes College, Oslo, Norway.

Front Endocrinol (Lausanne) ; 8: 160, 2017.

Article em En | MEDLINE | ID: mdl-28769873

Palavras-chave

diastolic dysfunction; endothelial and microvascular dysfunction; heart function; hypertension; inflammation; metabolic disease

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google